Condition
Smokeless Tobacco Use
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
80%
4 of 5 completed with results
Key Signals
4 with results100% success
Data Visualizations
Phase Distribution
4Total
P 2 (3)
P 3 (1)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT00888459Phase 2CompletedPrimary
A Pilot Study Evaluating Nicotine Lozenges and Self Help
NCT01067586CompletedPrimary
Novel Determinants and Measures of Smokeless Tobacco Use: Study 1
NCT00939029Phase 2CompletedPrimary
Highdose Nicotine Patch Therapy for Smokeless Tobacco Use
NCT00392379Phase 3CompletedPrimary
Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction
NCT00680615Phase 2CompletedPrimary
An Internet-Based Smokeless Tobacco Cessation Program for Teens
Showing all 5 trials